article thumbnail

Medicare Unveils First 10 Negotiated Drug Prices

Med Page Today

(MedPage Today) -- Sitagliptin (Januvia) saw the greatest drop in price among the list of 10 drugs whose new prices were announced Thursday under Medicare's drug price negotiation program. The price negotiation program was passed in 2022 as part.

Medicare 142
article thumbnail

Temporal Trends in Noninvasive and Invasive Cardiac Testing From 2010 to 2022 in the US Medicare Population

Circulation: Cardiovascular Imaging

in 2022, followed by single-photon emission computed tomography (CT) myocardial perfusion imaging, which decreased from 20.8% of cardiac testing use in 2011 and 67.7% Decreased use was also observed for exercise treadmill testing (2.3% to 1.7%), stress echocardiography (3.6% to 2.6%), multigated acquisition (0.4%

article thumbnail

Medicare Drug Cuts Target CVD Meds, Drive Debates

CardiacWire

The White House finally unveiled its negotiated Medicare drug prices , bringing 38%-76% reductions to the first 10 drugs, while drawing mixed industry reactions. Medicare drug price negotiations are one of the highlighted results of 2022’s Inflation Reduction Act, allowing CMS to negotiate drug prices for the very first time.

article thumbnail

Lower Prices For Medicare Drug Negotiation Program’s First 10 Drugs Announced

American College of Cardiology

The Centers for Medicare and Medicaid Services (CMS) on Aug. 15 announced the results of price negotiations for the first 10 drugs selected for the Medicare Drug Negotiation Program, made possible by the passage of the Inflation Reduction Act in 2022.

article thumbnail

Abstract 154: 10-Year Trend Analysis of Medicare Payment in Stroke Inpatient Hospital Admission

Stroke Journal

Percentage change in stroke admission cost adjusted for healthcare inflation between 2013-14 to 2021-22 weighted for the number in each stroke DRG was included in the analysis.Results:Between 2013 and 2022, nationwide there were a total of 2,007,005 unique stroke-related inpatient hospital claims, resulting in Medicare payments totaling $21.07

article thumbnail

Social Vulnerability and Long‐Term Cardiovascular Outcomes After COVID‐19 Hospitalization: An Analysis of the American Heart Association COVID‐19 Registry Linked With Medicare Claims Data

Journal of the American Heart Association

However, the association of socioeconomic vulnerability and outcomes after hospitalization is uncertain.Methods and ResultsAmerican Heart Association COVID19 Cardiovascular Disease Registry hospitalizations between March 1, 2020, and June 30, 2022, linked with Medicare feeforservice claims, were analyzed.

article thumbnail

iRhythm Unveils New Data Demonstrating Benefits of Long-Term Continuous Monitoring for Arrhythmia Detection

DAIC

Published March 24, 2022. Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. Treasure Island (FL): StatPearls Publishing; June 5, 2023. link] 4 National Heart, Lung, and Blood Institute. Arrhythmias - What Is an Arrhythmia? www.nhlbi.nih.gov. 2013;6(3):606-619.